2. Gene
  3. Camp - cathelicidin antimicrobial peptide Gene

Camp - cathelicidin antimicrobial peptide Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Mus musculus

同用名: CLP; Cnlp; MCLP; CAP18; Cramp; FALL39

基因 ID: 12796 | 基因类型: protein coding

关于 Camp

功能概要

This gene encodes a member of the cathelicidin family of Antimicrobial Peptides that play an important role in the defense against microbial Infection. The encoded preproprotein undergoes proteolytic processing to generate a mature polypeptide before secretion by host cells such as neutrophils, epithelial cells and macrophages. Mice lacking the encoded protein exhibit increased susceptibility to group A streptococcus and Escherichia coli infections. [provided by RefSeq, Oct 2015]

Camp 基因产物(1)

mRNA Protein Name
NM_009921.2 NP_034051.2 cathelicidin antimicrobial peptide precursor
基因本体论
  • 生物过程
  • 细胞组分
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in antimicrobial humoral immune response mediated by antimicrobial peptide IMP
IMP: 通过突变表型推断
17012259 MGI
acts upstream of or within defense response to Gram-negative bacterium IDA
IDA: 通过直接分析推断
9148921 MGI
involved in defense response to Gram-negative bacterium IMP
IMP: 通过突变表型推断
17012259 MGI
acts upstream of or within defense response to Gram-positive bacterium IMP
IMP: 通过突变表型推断
16177355 MGI
involved in defense response to Gram-positive bacterium IMP
IMP: 通过突变表型推断
17012259 MGI
acts upstream of or within defense response to bacterium IMP
IMP: 通过突变表型推断
23670560 MGI
involved in innate immune response IMP
IMP: 通过突变表型推断
17012259 MGI
acts upstream of or within killing by host of symbiont cells IMP
IMP: 通过突变表型推断
16177355 MGI
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in specific granule IDA
IDA: 通过直接分析推断
9148921 MGI
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

cathelicidin antimicrobial peptide

cathelin-like protein

cathelin-related antimicrobial peptide

相关产品

Approval
生物活性分子 (23)
目录号 产品名 作用方式
纯度 是否罕见病
HY-B0764 Bucladesine sodium 99.48% 是
HY-Y0682 Ethylenediaminetetraacetic acid ≥98.0% 否
HY-P0036 Octreotide 99.64% 否
HY-14773 Mirabegron Agonist 99.90% 是
HY-14302 Salmeterol Agonist 99.91% 是
HY-B0764A Bucladesine calcium 99.52% 是
HY-108742A Abaloparatide TFA Activator 99.86% 否
HY-17592 Bithionol Inhibitor 99.27% 否
HY-128932 Cefminox sodium 99.83% 否
HY-17034B Medetomidine hydrochloride Agonist 99.92% 否
HY-108742 Abaloparatide Activator 99.94% 否
HY-17453 Salmeterol xinafoate Agonist 99.96% 是
HY-Y0682A Ethylenediaminetetraacetic acid disodium dihydrate ≥98.0% 否
HY-B1898 Metadoxine 99.88% 是
HY-17034 Medetomidine Agonist 99.99% 否
HY-B1481 Isoetharine mesylate Agonist 99.87% 否
HY-B1505 Acefylline 99.96% 否
HY-B1639 Enoximone Inhibitor 98.07% 否
HY-B1209 Etofylline Inhibitor 99.72% 否
HY-B0813 Treprostinil diethanolamine Agonist 99.44% 否
HY-B1481A Isoetharine Agonist / 否
HY-B0764B Bucladesine Activator / 否
HY-P0036B Octreotide pamoate / 否
Clinical Phase
生物活性分子 (18)
目录号 产品名 作用方式
纯度 Phase
HY-W105700 Ethylenediaminetetraacetic acid sodium hydrate ≥98.0% Phase 4
HY-119486A (Rac)-Tavapadon Agonist 99.87% Phase 3
HY-P3366 Ecnoglutide Agonist 98.61% Phase 3
HY-16635 Setipiprant Antagonist 98.23% Phase 3
HY-130786 Denbufylline Inhibitor 99.92% Phase 3
HY-N0095 (S)-10-Hydroxycamptothecin 99.38% Phase 2
HY-12525 LGD-6972 Antagonist ≥98.0% Phase 2
HY-14973 Vidupiprant Antagonist 98.33% Phase 2
HY-109139 Taminadenant Antagonist 99.84% Phase 2
HY-101189 JNJ-39758979 Antagonist 99.71% Phase 2
HY-19436 Solabegron Agonist 99.89% Phase 2
HY-128656 LML134 Agonist 99.43% Phase 2
HY-106137 Tofimilast Inhibitor / Phase 2
HY-108047 MK-0873 Inhibitor / Phase 2
HY-120547 UCB-11056 / Phase 2
HY-10301 MK-3207 Antagonist 99.60% Phase 1
HY-P2878 Phosphodiesterase I / Phase 1
HY-124371 Amentoflavone hexaacetate / Phase 1
Pre-clinical Phase
生物活性分子 (363)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-15371 Forskolin 99.78% 否
HY-15979A H-89 dihydrochloride 99.34% 否
HY-12306 8-Bromo-cAMP sodium salt 99.91% 否
HY-15979 H-89 99.54% 否
HY-B1511 Cyclic AMP 99.95% 是
HY-100403 Ro 67-7476 Agonist 99.67% 否
HY-100927 Ro 20-1724 Inhibitor 99.34% 否
HY-103254 ML221 99.55% 否
HY-124696 PU139 Inhibitor 99.14% 否
HY-125791 cis-Epoxysuccinic acid Agonist 99.00% 否
HY-P1471 Adrenomedullin (AM) (22-52), human Antagonist 99.91% 否
HY-103193 NKH477 Activator 99.86% 否
HY-149164 BTB09089 Agonist 99.43% 否
HY-122197 ML339 Antagonist 99.88% 否
HY-100530D Rp-cAMPS sodium salt Antagonist 99.69% 否
HY-16558 Butein 99.95% 否
HY-12306A 8-Bromo-cAMP 99.41% 否
HY-B1511A Cyclic AMP sodium 99.97% 否
HY-103194 KH7 Inhibitor ≥99.0% 否
HY-N6727 Gliotoxin 99.51% 否
HY-107543 8-CPT-2Me-cAMP sodium Activator 99.58% 否
HY-128358 MR-L2 Activator 99.23% 否
HY-P1290A PKA Inhibitor Fragment (6-22) amide TFA Inhibitor 99.77% 否
HY-111673 8-CPT-Cyclic AMP sodium 99.92% 否
HY-P0222 PKI(5-24) Inhibitor 99.94% 否
HY-P1291 PKI 14-22 amide,myristoylated Inhibitor 99.91% 否
HY-117656 ESI-05 Inhibitor 99.94% 否
HY-103431 A68930 hydrochloride Agonist ≥98.0% 否
HY-108539 CE3F4 Inhibitor ≥98.0% 否
HY-P0097A Nonapeptide-1 acetate salt Antagonist 98.70% 否
HY-136172 ESI-08 Antagonist 99.25% 否
HY-P10138A human GIP(3-30), amide TFA Antagonist 98.82% 否
HY-108618 BC11-38 Inhibitor 99.42% 否
HY-18740A Trequinsin hydrochloride Inhibitor 99.93% 否
HY-100984 HA-100 Inhibitor 99.80% 否
HY-117958 HJC0197 Inhibitor 99.58% 否
HY-111385 UNC9994 hydrochloride 98.83% 否
HY-124717 YC-001 Antagonist 99.43% 否
HY-15478 WZ811 Antagonist 99.79% 否
HY-W012980 Isovaleric acid Activator ≥98.0% 否
HY-103192 MDL12330A Inhibitor 99.82% 否
HY-101572 MHP Activator 98.23% 否
HY-133529 PA-8 97.00% 否
HY-100013C 2-PCCA hydrochloride 99.63% 否
HY-129658A TT-OAD2 Agonist 99.77% 否
HY-16642A LY2828360 Agonist 99.50% 否
HY-129421 PA-9 99.60% 否
HY-N2118 Bilobetin Activator 99.39% 否
HY-B0392 (S)-(+)-Rolipram 99.77% 否
HY-103565 AMN082 Agonist 99.83% 否
HY-14899 Taprenepag Agonist 98.79% 否
HY-50906 LY404039 Agonist ≥98.0% 否
HY-103302 SUN B8155 Agonist 99.24% 否
HY-103547 L-168049 Antagonist 99.93% 否
HY-10797 CJ-42794 Antagonist 98.96% 否
HY-112612A RTI-13951-33 hydrochloride 98.56% 否
HY-16900A (R)-(-)-Rolipram Inhibitor 99.89% 否
HY-110218 CW 008 Agonist 98.15% 否
HY-119168 LP-471756 Antagonist 99.69% 否
HY-124571 ZQ-16 Agonist 99.88% 否
HY-14550 TP-10 Inhibitor 99.88% 否
HY-P1845A PACAP-38 (31-38), human, mouse, rat TFA Inducer 98.33% 否
HY-103186 MRS-1706 Antagonist 98.07% 否
HY-153967 BLU0588 Inhibitor 95.92% 否
HY-N0113 Hordenine Inhibitor 99.88% 否
HY-P0172A ATI-2341 TFA Agonist 96.71% 否
HY-P1845 PACAP-38 (31-38), human, mouse, rat Inducer 99.98% 否
HY-116818 Crebinostat Inhibitor 99.79% 否
HY-124151 Adenosine-2'-monophosphate Activator 99.91% 否
HY-12887 Piclamilast Inhibitor 99.63% 否
HY-156863 GRK2 Inhibitor 2 Inhibitor 98.88% 否
HY-P1291A PKI 14-22 amide,myristoylated TFA Inhibitor 99.38% 否
HY-100530C Sp-cAMPS sodium salt 99.45% 否
HY-101232 Tiotidine Antagonist 99.28% 否
HY-N3945 Glaucine 99.57% 否
HY-P0248 Kemptide 98.81% 否
HY-P1595 CREBtide 98.96% 否
HY-18978 GR79236 Agonist 99.89% 否
HY-B1511R Cyclic AMP (Standard) / 否
HY-P10138 human GIP(3-30), amide Antagonist 98.73% 否
HY-100936 Etazolate hydrochloride 98.00% 否
HY-103180 2'-MeCCPA Agonist 99.79% 否
HY-118941 BAY 73-1449 Antagonist 99.99% 否
HY-18286 NCGC00229600 Antagonist 99.67% 否
HY-P1913A Calcitonin Gene Related Peptide (CGRP) II, rat TFA Activator 99.89% 否
HY-102076 0990CL Inhibitor ≥98.0% 否
HY-116530 9-Cyclopentyladenine monomethanesulfonate Inhibitor 99.16% 否
HY-116874 SKF 83822 Agonist 98.66% 否
HY-14340 WAY-181187 Agonist 98.07% 否
HY-N2038 3,​5,​6,​7,​8,​3',​4'-​Heptemthoxyflavone Inhibitor 99.85% 否
HY-N2168 Pinoresinol 4-O-β-D-glucopyranoside 99.89% 否
HY-P1296 Urocortin, rat Agonist 96.58% 否
HY-P2249 ELA-21 (human) 98.92% 否
HY-106358 Andolast free base Inhibitor 98.09% 否
HY-103322 6-Bnz-cAMP sodium salt Activator ≥98.0% 否
HY-111896 7-Methoxyrosmanol Inhibitor 98.56% 否
HY-134598A 653-47 hydrochloride Inhibitor 99.42% 否
HY-135119 Salmeterol-d3 Inhibitor 98.91% 否
HY-141495 (Rac)-Razpipadon Agonist 97.09% 否
HY-148867 UCM-1306 Modulator 99.61% 否
HY-N1860 3-O-Methylquercetin Inhibitor 99.98% 否
HY-P1250 RFRP-3(human) Agonist 99.21% 否
HY-P2197 ELA-11(human) 99.03% 否
HY-B1511S Cyclic AMP-13C5 97.45% 否
HY-108539A (R)-CE3F4 Inhibitor ≥99.0% 否
HY-123820 LY3020371 hydrochloride Antagonist 99.18% 否
HY-106045 Imazodan Inhibitor 99.38% 否
HY-106739 Motapizone Inhibitor ≥95.0% 否
HY-113689 GAT211 Agonist 99.98% 否
HY-132240 SF-22 Antagonist 99.49% 否
HY-147395 GPR52 agonist-1 99.76% 否
HY-162734 BRD5075 Inhibitor 98.03% 否
HY-P1106A K41498 TFA Antagonist 99.40% 否
HY-N0113B Hordenine hydrochloride Inhibitor 99.82% 否
HY-RS16241 Camp Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-100530B Sp-cAMPS / 否
HY-103369 PG01 Activator ≥98.0% 否
HY-108258 PSN 375963 Agonist 99.96% 否
HY-108621 RS-25344 hydrochloride Inhibitor 99.93% 否
HY-108626 ML154 Antagonist 98.02% 否
HY-117829 UNC9994 98.06% 否
HY-125957 A-3 hydrochloride Inhibitor 99.75% 否
HY-131032 KI-7 Agonist 99.16% 否
HY-134266 8-Bromo-AMP 98.81% 否
HY-151392 LPA5 antagonist 2 Antagonist 99.62% 否
HY-161106 OX04528 Agonist 99.71% 否
HY-19026 Siguazodan Inhibitor ≥99.0% 否
HY-P1065 Apelin-36(rat, mouse) 99.12% 否
HY-P1597 Malantide 96.37% 否
HY-P4823 pTH (1-37) (human) 99.85% 否
HY-P5189A His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA 99.31% 否
HY-105118A Zaldaride maleate Antagonist ≥98.0% 否
HY-112612 RTI-13951-33 / 否
HY-N0113S Hordenine-d6 Inhibitor 98.03% 否
HY-100530 Rp-cAMPS triethylammonium salt Antagonist 99.53% 否
HY-101317 TAN-67 dihydrobromide Agonist ≥99.0% 否
HY-103178 MRE3008F20 Antagonist 99.70% 否
HY-103565A AMN082 free base Agonist 99.07% 否
HY-107544 8-pCPT-2'-O-Me-cAMP-AM ≥99.0% 否
HY-110003 Arachidonylcyclopropylamide Agonist ≥98.0% 否
HY-111082 ISAM-140 Inhibitor 99.85% 否
HY-120994 Rp-8-CPT-cAMPS sodium Antagonist ≥99.0% 否
HY-121541 CB-25 99.02% 否
HY-123396 8-Chloro-cAMP Modulator ≥99.0% 否
HY-131763 2'-O-MB-cAMP sodium 99.94% 否
HY-132993 Hcyb1 Inhibitor 98.24% 否
HY-156649 Vorbipiprant Antagonist 99.72% 否
HY-156772 GPR88 agonist 2 Agonist 99.57% 否
HY-401913 endo CNTinh-03 Inhibitor 99.96% 否
HY-N6901 Luteolin 7-sulfate ≥95.0% 否
HY-P10716 Exendin-P5 Activator / 否
HY-P2197A ELA-11(human) TFA Chemical 99.03% 否
HY-130304 8-Isoprostaglandin E2 Activator ≥99.0% 否
HY-126383 Spilanthol / 否
HY-106358A Andolast Inhibitor / 否
HY-126250 NPD-1335 Inhibitor 98.10% 否
HY-129658 TT-OAD2 free base Agonist / 否
HY-100530A Rp-cAMPS Antagonist / 否
HY-100543 Zenidolol Antagonist / 否
HY-100984A HA-100 hydrochloride Inhibitor / 否
HY-101189B JNJ-39758979 dihydrochloride Antagonist / 否
HY-101826A ER21355 hydrochloride Inhibitor / 否
HY-101863 CB-6673567 / 否
HY-105118 Zaldaride Inhibitor / 否
HY-106045A Imazodan hydrochloride Inhibitor / 否
HY-107046 UK-432097 Agonist / 否
HY-107506 Ro 67-4853 Agonist 99.90% 否
HY-107612 GPBAR-A Agonist / 否
HY-108258A PSN 375963 hydrochloride Agonist / 否
HY-108991 T-0509 Agonist / 否
HY-110005 Sp-cAMPS triethylamine / 否
HY-110040 L759633 Agonist / 否
HY-110070 DL-AP4 sodium Agonist / 否
HY-110161 sst2 Receptor agonist-1 Agonist / 否
HY-110366 WAY-181187 oxalate Agonist / 否
HY-112363 Aloisine A / 否
HY-114539 L-750667 triHydrochloride Antagonist / 否
HY-114990 EMD 57439 Inhibitor / 否
HY-115553 DETQ Agonist / 否
HY-115769 1,2-Didecanoylglycerol Activator / 否
HY-116119 BDF 9148 Activator / 否
HY-116312 8-CPT-2'-O-Me-cAMP Activator / 否
HY-116445 UNC9975 / 否
HY-116540 L 858051 / 否
HY-116806 AF-2785 Inhibitor / 否
HY-117181 UK-1745 Inhibitor / 否
HY-117715 CK-3197 / 否
HY-118175 RG 14921 / 否
HY-120684 PDE10-IN-6 / 否
HY-120687 A68930 Agonist / 否
HY-120826 A2AAR/hMAO-B-IN-1 Inhibitor / 否
HY-120828 Albenatide Agonist / 否
HY-120879 PF2562 Agonist / 否
HY-120994A Rp-8-CPT-cAMPS Antagonist / 否
HY-120994B Sp-8-CPT-cAMPS Activator / 否
HY-122147 L-644698 Agonist / 否
HY-123008 Reproterol hydrochloride / 否
HY-123335 L-796,778 Agonist / 否
HY-123782 (Rac)-UK-414495 Inhibitor / 否
HY-125020 NCGC00135472 / 否
HY-126754 Archangelicin Inhibitor / 否
HY-12880 HA-100 dihydrochloride Inhibitor / 否
HY-129210 KMUP-4 / 否
HY-130176 UFP-512 / 否
HY-131768 2'-O-Succinyl-cAMP ≥99.0% 否
HY-134263 8-Br-cAMP-AM Agonist / 否
HY-134264 8-Br-2'-O-Me-cAMP / 否
HY-134283 8-Benzylthio-cAMP Activator / 否
HY-134298 8-CPT-6-Phe-cAMP Activator / 否
HY-134299 8-CPT-cAMP-AM / 否
HY-134321 8-Azido-cAMP / 否
HY-134598 653-47 Inhibitor / 否
HY-136501 MRS2395 Antagonist / 否
HY-137308 15(R)-Prostaglandin D2 / 否
HY-137638 Sp-5,6-DCl-cBIMPS Activator / 否
HY-137638A Sp-5,6-DCl-cBIMPS sodium Activator / 否
HY-137640A Sp-8-Br-cAMPS sodium Agonist / 否
HY-139486 AM-8123 Agonist / 否
HY-14132 BMS-665053 Antagonist / 否
HY-142972 19(S)-HETE Agonist / 否
HY-14302S1 Salmeterol-d5 Agonist / 否
HY-144705 GAT564 Modulator / 否
HY-14773S (Rac)-Mirabegron-d5 Agonist / 否
HY-147751 APJ receptor agonist 6 / 否
HY-147946 PDE1-IN-4 Inhibitor / 否
HY-148827 GEM-231 Inhibitor / 否
HY-148827A GEM-231 sodium Inhibitor / 否
HY-149247 Antipsychotic agent-2 / 否
HY-149933 AM841 Activator / 否
HY-150056 CB1R Allosteric modulator 3 98.05% 否
HY-150057 CB1R Allosteric modulator 4 Modulator / 否
HY-150073 DS01080522 Inhibitor / 否
HY-156536 RXFP1 receptor agonist-1 / 否
HY-156537 RXFP1 receptor agonist-2 / 否
HY-156538 RXFP1 receptor agonist-3 / 否
HY-156539 RXFP1 receptor agonist-4 / 否
HY-156540 RXFP1 receptor agonist-5 / 否
HY-156541 RXFP1 receptor agonist-6 / 否
HY-156542 RXFP1 receptor agonist-7 / 否
HY-156543 RXFP1 receptor agonist-8 / 否
HY-158179 A3AR agonist 3 Agonist / 否
HY-158180 A3AR agonist 4 Agonist / 否
HY-158181 A3AR agonist 5 Agonist / 否
HY-160734 Aleniglipron Agonist / 否
HY-160864 Torbafylline Inhibitor / 否
HY-160921 Capeserod Agonist / 否
HY-161107 OX04529 Agonist / 否
HY-161405 NPFF1-R antagonist 1 Inhibitor / 否
HY-161506 PDE1-IN-7 Inhibitor / 否
HY-161817 TGR5 agonist 5 Agonist / 否
HY-162394 Vasopressin V2 receptor antagonist 2 Antagonist / 否
HY-162401 AZ7976 Agonist / 否
HY-162581 FCPR16 Inhibitor / 否
HY-162735 BRD5080 / 否
HY-162787 Adenosine receptor antagonist 5 Antagonist / 否
HY-163345 5-HT7R antagonist 2 Antagonist / 否
HY-163530 GPR41 modulator 1 Modulator / 否
HY-163651 (R)-Vorbipiprant Antagonist / 否
HY-163996 DD202-114 Agonist 98.47% 否
HY-168558 PDE4B/D-IN-4 Inhibitor / 否
HY-17453S Salmeterol-d3 xinafoate Agonist / 否
HY-17453S1 Salmeterol-13C6 xinafoate Agonist / 否
HY-19436A Solabegron hydrochloride Agonist / 否
HY-19755 S-5751 Antagonist / 否
HY-D1187 2-Aza-ε-cAMP / 否
HY-D1187A 2-Aza-ε-cAMP sodium / 否
HY-N0113A Hordenine sulfate / 否
HY-N0113R Hordenine (Standard) Inhibitor / 否
HY-N1189 DL-Syringaresinol diacetate / 否
HY-N13132 Hellicoside Inhibitor / 否
HY-N2658 5,7-Diacetoxy-8-methoxyflavone Inhibitor / 否
HY-N3324 Mangostanol Inhibitor / 否
HY-N3464 Isopedicin Inhibitor / 否
HY-N3550 Catalponol / 否
HY-N3773 Dodoviscin A Inhibitor / 否
HY-N6256 Ilexsaponin B2 Inhibitor / 否
HY-N8092 Kushenol B Inhibitor / 否
HY-P0097 Nonapeptide-1 Antagonist 99.04% 否
HY-P0222A PKI(5-24) TFA Inhibitor / 否
HY-P0252B α-MSH free acid Agonist / 否
HY-P10047 PKItide Inhibitor / 否
HY-P1065A Apelin-36(rat, mouse) TFA / 否
HY-P10728 B7-33 Agonist / 否
HY-P1106 K41498 Antagonist / 否
HY-P1250A RFRP-3(human) TFA Agonist / 否
HY-P1290 PKA Inhibitor Fragment (6-22) amide Inhibitor / 否
HY-P1296A Urocortin, rat TFA Agonist / 否
HY-P1320 [Nphe1]Nociceptin(1-13)NH2 Antagonist / 否
HY-P1320A [Nphe1]Nociceptin(1-13)NH2 TFA Antagonist / 否
HY-P1325 BWX 46 Agonist / 否
HY-P1471A Adrenomedullin (AM) (22-52), human TFA Antagonist / 否
HY-P1595A CREBtide TFA 98.72% 否
HY-P1597A Malantide TFA / 否
HY-P1817 PACAP-38 (16-38), human, mouse, rat / 否
HY-P1913 Calcitonin Gene Related Peptide (CGRP) II, rat Activator / 否
HY-P2285 AC 253 Antagonist / 否
HY-P2847 Urocortin II, mouse Inhibitor / 否
HY-P2867 Phosphodiesterase II, Bovine Spleen / 否
HY-P3544 Lys-[Hyp3]-Bradykinin Agonist / 否
HY-P3570 Adipokinetic hormone II (Locusta migratoria) Inducer / 否
HY-P3572 Adipokinetic hormone I (Locusta migratoria) Inducer / 否
HY-P3770 Phosphate acceptor peptide Inhibitor / 否
HY-P3777 β-Bag cell peptide Inhibitor / 否
HY-P3786 H-Arg-Gly-Tyr-Ala-Leu-Gly-OH Inhibitor / 否
HY-P3930 PKI (5-24),amide Inhibitor / 否
HY-P4497 Prolylserine Inhibitor / 否
HY-P4817 Human PTH-(1-31) / 否
HY-Q40876 BBT Modulator 99.71% 否
HY-RS01870 CAMP Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-W127485 cis-9,10-Methyleneoctadecanoic Acid / 否
HY-W746031 WAY-181187 hydrochloride Agonist / 否
HY-105912 ONO 1082 / 否
HY-111527 PPZ2 / 否
HY-113513 5-HEPE / 否
HY-114727 PDE7-IN-4 / 否
HY-119333 NNC 11-1607 Agonist / 否
HY-121249 Capeserod hydrochloride Agonist / 否
HY-122189 Akuammine / 否
HY-122622 PF-04471141 hydrochloride / 否
HY-123396A 8-Chloro-cAMP sodium Modulator / 否
HY-124381 ML10375 / 否
HY-124681 NY0116 / 否
HY-12525A LGD-6972 sodium Antagonist / 否
HY-131421 8-PIP-cAMP Activator / 否
HY-131764 2'-O-MB-cGMP sodium Inhibitor / 否
HY-131766 2'-O-Me-cAMP / 否
HY-131772 2-AHA-cAMP / 否
HY-131777 2-Cl-cAMP / 否
HY-131823 5,6-DCl-cBIMP Agonist / 否
HY-131824 5,6-DM-cBIMP Agonist / 否
HY-131842 6-Bn-cAMP Activator / 否
HY-131844 6-Bnz-5'-AMP / 否
HY-134254 8-AHA-cAMP / 否
HY-134302 8-HA-cAMP Activator / 否
HY-134308 8-NBD-cAMP sodium / 否
HY-134325 8-OH-cAMP Agonist / 否
HY-134332 8-pCPT-5'-AMP Activator / 否
HY-134340 8-pMeOPT-2'-O-Me-cAMP / 否
HY-134348 8-pHPT-2'-O-Me-cAMP Agonist / 否
HY-134389 6-Phe-cAMP Activator / 否
HY-134395 6-MB-cAMP / 否
HY-134406 6-Cl-cPuMP sodium Modulator / 否
HY-136942 DS1 Agonist / 否
HY-137370 2-Hexynyl-5′-N-ethylcarboxamidoadenosine / 否
HY-137381 6-Bnz-cAMP Inhibitor / 否
HY-137530 8-MA-cAMP Agonist / 否
HY-137624 Sp-cAMPS-AM Activator / 否
HY-137628 Sp-8-PIP cAMP Agonist / 否
HY-137630 Sp-8-pCPT-2'-O-Me-cAMPS Activator / 否
HY-137632 Sp-8-Cl-cAMPS / 否
HY-137635 Sp-6-Phe-cAMPS Activator / 否
HY-137640 Sp-8-Br-cAMPS Agonist / 否
HY-137640B Rp-8-Br-cAMPS Inhibitor / 否
HY-137641 Sp-8-Br-2'-O-Me-cAMPS Activator / 否
HY-137646 Sp-2-Cl-cAMPS / 否
HY-153542 AP-C6 Inhibitor / 否
HY-167856 RTI-122 Agonist / 否
HY-69172 RS-25344 Inhibitor / 否
HY-B1505A Acefylline piperazine / 否
HY-W394717 BGC-20-1531 / 否
HY-P0172 ATI-2341 Agonist / 否
HY-P0291 Kemptide Phospho-Ser5 / 否
HY-U00341 ST4206 Antagonist / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Camp NCBI NCBI:820
Canis familiaris Camp NCBI NCBI:442947
Macaca fascicularis Camp NCBI NCBI:102139204
Rattus norvegicus Camp NCBI NCBI:316010
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z